4-(1H-Indol-3-YL)cyclohexanone → 4-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-cyclohexanone
Reaction equation
N1C2C(=CC=CC=2)C(C2CCC(=O)CC2)=C1.[CH3:17][O:18][C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][C:20]=1[N:25]1[CH2:30][CH2:29][N:28]([CH:31]2[CH2:40][CH2:39][C:34]3(OCC[O:35]3)[CH2:33][CH2:32]2)[CH2:27][CH2:26]1>>[CH3:17][O:18][C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][C:20]=1[N:25]1[CH2:30][CH2:29][N:28]([CH:31]2[CH2:40][CH2:39][C:34](=[O:35])[CH2:33][CH2:32]2)[CH2:27][CH2:26]1Participants
3
Procedure
This compound was prepared in the manner described above for intermediate 3a by replacing 3-(1,4-dioxa-spiro[4,5]dec-8-yl)-1H-indole with 1-(2-methoxy-phenyl)-4-(1,4-dioxa-spiro[4,5]dec-8-yl)-piperazine (5.0 g, 15 mmol) to afford 4.0 g (93%) of the title compound.
Workup
- customThis compound was prepared in the manner
Sources & evidence
- ORD record
- ord-6654b02fe8db4c36ae2ab466c091fc0d
- Source dataset
- uspto-grants-2001_11
- Patent number
- US06313126B1
Reaction notes
Loading…